229 citations
Cite
SaveGo to paper →
Elsevier
JID Innovations Template
Write in a clean editor, then format for JID Innovations in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the JID Innovations format
JID Innovations is a peer-reviewed journal published by Elsevier, covering Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Skin Protection and Aging.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, JID Innovations 12 (2023) 45–58.
Formats any DOI in JID Innovations style. No sign-up. |
| Publishes research in | Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Skin Protection and Aging Cutaneous Melanoma Detection and Management Autoimmune Bullous Skin Diseases |
| ISSN | 2667-0267 |
| Citation impact (2-yr) | 1.97 |
| h-index | 26 |
| i10-index | 87 |
| Total citations | 3,334 |
| Article processing charge | $2,000 |
| Open access | Yes |
| Top institutions publishing here | Harvard University |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in JID Innovations per year
Citation impact of JID Innovations by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in JID Innovations
Pemphigus is an epidemiologically heterogeneous group of autoimmune bullous diseases comprising pemphigus vulgaris (PV), pemphigus foliaceus, paraneoplastic pemphigus, IgA pemphigus, and pemphigus herpetiformis. Recently, our knowledge about the frequency of pemphigus, which is highly variable between different populations, has considerably expanded, and the first non-HLA genes associated with PV have been identified. In addition, a…
135 citations
Cite
SaveGo to paper →
Over the past decades, tremendous success in the treatment of psoriasis has been achieved using biologics, such as neutralizing antibodies against TNF/TNFR, IL-23, and IL-17A/IL-17RA. Although psoriatic skin lesions appear to resolve after treatment with these biologics, lesions often recur after therapy is discontinued or during therapy. Memory T cells residing in the skin have…
96 citations
Cite
SaveGo to paper →
Recently, Jak inhibitors such as baricitinib, upadacitinib, and abrocitinib were approved for the treatment of atopic dermatitis (AD) in addition to biologics, including dupilumab, tralokinumab, and nemolizumab. The increase in treatment options can be a benefit to patients with AD. Meanwhile, it could make it difficult for physicians to choose the best treatment among those…
90 citations
Cite
SaveGo to paper →
Atopic dermatitis (AD) is a chronic inflammatory skin disease with pruritus, characterized by recurrent eczema with exacerbations and remissions. AD impairs patients' QOL and places a heavy burden on patients. Recently, dupilumab, an anti-IL-4Rα antibody, was approved for the treatment of patients with moderate-to-severe AD who are refractory to topical agents and/or conventional systemic therapy.…
79 citations
Cite
SaveGo to paper →
Related journal templates
JID Innovations template — frequently asked questions
How do I write a paper in the JID Innovations format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the JID Innovations template. When you export, DocuGuru compiles the paper into the official Elsevier format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does JID Innovations use?
JID Innovations uses Numbered (Elsevier) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: [1] A. Smith, B. Jones, C. Lee, A representative article title, JID Innovations 12 (2023) 45–58.
Do I need to know LaTeX to submit to JID Innovations?
No. DocuGuru generates the elsarticle LaTeX class and compiles the PDF for you in the background, so you get a Elsevier-ready JID Innovations document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the JID Innovations template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the JID Innovations format with correct headings, figures, tables, and numbered citations.
Who publishes JID Innovations?
JID Innovations is a multidisciplinary journal published by Elsevier. DocuGuru's JID Innovations template matches Elsevier's official submission format.
Can I export a submission-ready JID Innovations PDF?
Yes — DocuGuru produces a PDF built with the official JID Innovations template (the elsarticle class) that is ready to submit to Elsevier, together with the matching LaTeX source files.
How much does the JID Innovations template cost?
You can start writing in the JID Innovations template for free. Exporting the final submission-ready JID Innovations PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.